Edgewise Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Edgewise Therapeutics Inc
TickerEWTX
CIK #0001710072
CUSIP28036F105
SectorLife Sciences - Pharmaceutical Preparations
Address3415 Colorado Ave, Boulder, CO 80303
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Edgewise Therapeutics Inc 2020-12-10 95.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001710072] 10-K
[0001710072] 10-Q
[0001710072] 3
[0001710072] 4
[0001710072] 8-K
[0001710072] D
[0001710072] SC 13D
[0001710072] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Janus Henderson Group PLC Edgewise Therapeutics Inc [2026-05-15] 0.0
Perceptive Advisors LLC Edgewise Therapeutics Inc [2025-02-21] 0.0
Janus Henderson Group PLC Edgewise Therapeutics Inc [2025-02-14] 0.0
Paradigm Biocapital Advisors LP Edgewise Therapeutics Inc [2025-02-03] 0.0
Baker Bros Advisors LP Edgewise Therapeutics Inc [2024-11-14] 6.2
BlackRock Inc Edgewise Therapeutics Inc [2024-11-08] 6.8
BlackRock Inc Edgewise Therapeutics Inc [2024-10-22] 6.8
BlackRock Inc Edgewise Therapeutics Inc [2024-02-02] 5.2
RA Capital Management LP Edgewise Therapeutics Inc [2024-01-29] 9.6
EcoR1 Capital LLC Edgewise Therapeutics Inc [2022-09-26] 5.5
Deep Track Capital LP Edgewise Therapeutics Inc [2022-09-23] 5.34
RA Capital Management LP Edgewise Therapeutics Inc [2022-02-14] 5.3
FMR LLC Edgewise Therapeutics Inc [2022-02-09] 0.0
Citadel Advisors LLC Edgewise Therapeutics Inc [2022-01-13] 5.0
Citadel Advisors LLC Edgewise Therapeutics Inc [2021-07-12] 4.8
Cormorant Global Healthcare Master Fund LP Edgewise Therapeutics Inc [2021-05-18] 3.37
US Venture Partners Xi LP Edgewise Therapeutics Inc [2021-05-03] 7.1
OrbiMed Advisors LLC Edgewise Therapeutics Inc [2021-04-08] 27.8
Viking Global Investors LP Edgewise Therapeutics Inc [2021-04-05] 7.0
Novo Holdings A/S Edgewise Therapeutics Inc [2021-03-31] 11.4
Flynn James E Edgewise Therapeutics Inc [2021-03-30] 8.27
Form 3/4/5 Filer 2011 - 2026
Edgewise Therapeutics Inc
Russell Alan J
Fox Jonathan C
Brege Laura
Morris Arlene
Thompson Peter A
Edris Badreddin
Martin Christopher Nathan
Donovan Joanne M
Nofi Michael
Blaustein Robert
Moore John R
Koch Kevin
Derakhshan Behrad
Carruthers R Michael
Root Jonathan D
OrbiMed Advisors LLC
OrbiMed Capital GP VI LLC
OrbiMed Genesis GP LLC
Semigran Marc
Novo Holdings A/S
Wellington Biomedical Innovation Master Investors Cayman I
Deerfield Private Design Fund IV LP
Deerfield Management Company LP
Flynn James E
Deerfield Mgmt IV LP
Harrison Kenneth PhD
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Donovan Joanne M
Common Stock
2026-03-31 Sell 21,338 $32.12 685,377
Donovan Joanne M
Stock Option (Right to Buy) · derivative
2026-03-31 Option exercise 21,338 $0.00
Donovan Joanne M
Common Stock
2026-03-31 Option exercise 21,338 $7.08 151,073
Donovan Joanne M
Common Stock
2026-03-27 Sell 9,623 $30.98 298,121
Donovan Joanne M
Common Stock
2026-03-27 Sell 6,735 $30.98 208,650
Edris Badreddin
Stock Option (Right to Buy) · derivative
2026-01-21 Option exercise 17,236 $0.00
Edris Badreddin
Stock Option (Right to Buy) · derivative
2026-01-21 Option exercise 7,605 $0.00
Edris Badreddin
Common Stock
2026-01-21 Sell 66,477 $29.44 1,957,083
Edris Badreddin
Stock Option (Right to Buy) · derivative
2026-01-21 Option exercise 66,477 $0.00
Edris Badreddin
Common Stock
2026-01-21 Option exercise 66,477 $1.93 128,301
Edris Badreddin
Common Stock
2026-01-21 Sell 10,463 $29.44 308,031
Edris Badreddin
Common Stock
2026-01-21 Option exercise 17,236 $0.64 11,031
Edris Badreddin
Common Stock
2026-01-21 Sell 13,690 $29.44 403,034
Edris Badreddin
Stock Option (Right to Buy) · derivative
2026-01-21 Option exercise 13,690 $0.00
Edris Badreddin
Common Stock
2026-01-21 Sell 7,605 $29.44 223,891
Edris Badreddin
Common Stock
2026-01-21 Option exercise 7,605 $0.71 5,400
Edris Badreddin
Common Stock
2026-01-21 Option exercise 13,690 $0.39 5,339
Edris Badreddin
Common Stock
2026-01-21 Option exercise 10,463 $1.93 20,194
Edris Badreddin
Stock Option (Right to Buy) · derivative
2026-01-21 Option exercise 10,463 $0.00
Edris Badreddin
Common Stock
2026-01-21 Sell 17,236 $29.44 507,428
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 217 119,636,562
2025-12-31 203 122,757,403
2025-09-30 176 112,286,014
2025-06-30 179 118,846,838
2025-03-31 201 109,668,768
2024-12-31 208 99,928,997
2024-09-30 181 104,003,649
2024-06-30 141 101,492,573
2024-03-31 130 92,455,346
2023-12-31 117 79,886,195
2023-09-30 86 68,439,950
2023-06-30 96 69,513,016
Form 13F Holdings
Firm Period DFND Voting Shares
Peregrine Capital Management LLC [2026-06-30] SOLE 73,798 198,570
Moody Aldrich Partners LLC [2026-06-30] SOLE 45,745 104,952
Eleva Capital SAS [2026-06-30] SOLE 0 17,460
Connecticut Capital Management Group LLC [2026-06-30] OTR 0 9,824
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 5,466 5,466
PSP Research LLC [2026-06-30] SOLE 0 5,000
Gamma Investing LLC [2026-06-30] DFND 2,107 2,107
Farther Finance Advisors LLC [2026-06-30] SOLE 0 558
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 294 294
Fortitude Family Office LLC [2026-06-30] SOLE 160 160
Versant Capital Management Inc [2026-06-30] SOLE 120 120
BFSG LLC [2026-06-30] SOLE 0 100
Handelsbanken Fonder AB [2026-06-30] SOLE 0 30
Ares Financial Consulting LLC [2026-06-30] SOLE 23 23
IFP Advisors LLC [2026-06-30] SOLE 4 4
GHP Investment Advisors Inc [2026-06-30] SOLE 3 3
Hughes Financial Services LLC [2026-06-30] SOLE 3 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com